Merck’s Covid pill hailed after cutting hospitalisations by 50%
WASHINGTON: US pharmaceutical company Merck said on Friday it will seek authorisation of its oral drug molnupiravir for Covid-19 after it was shown to reduce the chance newly infected patients were hospitalised by 50 percent. A simple pill to treat the coronavirus has been sought since the start of the pandemic and Friday’s announcement was … Read more